BIO

BIO Deferred Revenue

$0.00Quarterly · USD

Period ending:

BIO FY Deferred RevenueUSD
BIO FY Deferred Revenue1985-12-31: $0.001986-12-31: $0.001987-12-31: $0.001988-12-31: $0.001989-12-31: $0.001990-12-31: $0.001991-12-31: $0.001992-12-31: $0.001993-12-31: $0.001994-12-31: $0.001995-12-31: $0.001996-12-31: $0.001997-12-31: $0.001998-12-31: $0.001999-12-31: $0.002000-12-31: $0.002001-12-31: $0.002002-12-31: $0.002003-12-31: $0.002004-12-31: $0.002005-12-31: $0.002006-12-31: $0.002007-12-31: $0.002008-12-31: $0.002009-12-31: $0.002010-12-31: $0.002011-12-31: $24.32M2012-12-31: $26.29M2013-12-31: $26.39M2014-12-31: $26.72M2015-12-31: $29.68M2016-12-31: $31.00M2017-12-31: $28.23M2018-12-31: $26.94M2019-12-31: $33.74M2020-12-31: $42.47M2021-12-31: $50.85M2022-12-31: $52.21M2023-12-31: $0.002024-12-31: $0.002025-12-31: $0.00$52.21M$0.00
1985-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

BIO deferred revenue history

Revenue received but not yet earned. The available annual fiscal periods series contains 41 observations from Dec 31, 1985 to Dec 31, 2025.

Bio-Rad Laboratories, Inc. Class A Common Stock Deferred Revenue — Annual fiscal periods (USD)
Period endingDeferred Revenue (USD)
0
0
0
52,211,000
50,852,000
42,468,000
33,735,000
26,936,000
28,233,000
31,003,000
29,683,000
26,716,000
26,390,000
26,288,000
24,322,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

Compare deferred revenue

All BIO financial metrics · BIO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.